Medicskin Holdings Dirección

Dirección controles de criterios 2/4

El CEO de Medicskin Holdings' es Kwok Leung Kong , nombrado en Mar 2018, tiene una permanencia de 6.08 años. compensación anual total es HK$6.20M, compuesta por 68.1% salario y 31.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 69.28% de las acciones de la empresa, por valor de HK$39.58M. La antigüedad media del equipo directivo y de la junta directiva es de 10.1 años y 9.3 años, respectivamente.

Información clave

Kwok Leung Kong

Chief Executive Officer (CEO)

HK$6.2m

Compensación total

Porcentaje del salario del CEO	68.1%
Permanencia del CEO	6.2yrs
Participación del CEO	69.3%
Permanencia media de la dirección	10.2yrs
Promedio de permanencia en la Junta Directiva	9.4yrs

Actualizaciones recientes de la dirección

We Think Some Shareholders May Hesitate To Increase Medicskin Holdings Limited's (HKG:8307) CEO Compensation

Sep 15

Recent updates

We Think Some Shareholders May Hesitate To Increase Medicskin Holdings Limited's (HKG:8307) CEO Compensation

Sep 15

Here's Why Shareholders May Want To Be Cautious With Increasing Medicskin Holdings Limited's (HKG:8307) CEO Pay Packet

Sep 16

Here's Why We Think Medicskin Holdings (HKG:8307) Is Well Worth Watching

Jul 18

Investor Optimism Abounds Medicskin Holdings Limited (HKG:8307) But Growth Is Lacking

Jun 11

A Look At The Fair Value Of Medicskin Holdings Limited (HKG:8307)

Feb 25

Shareholders Will Probably Hold Off On Increasing Medicskin Holdings Limited's (HKG:8307) CEO Compensation For The Time Being

Sep 15

Can Mixed Fundamentals Have A Negative Impact on Medicskin Holdings Limited (HKG:8307) Current Share Price Momentum?

Feb 11

Our Take On Medicskin Holdings' (HKG:8307) CEO Salary

Dec 16

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Kwok Leung Kong en comparación con los beneficios de Medicskin Holdings?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2023	n/a	n/a	-HK$2m
Jun 30 2023	n/a	n/a	-HK$3m
Mar 31 2023	HK$6m	HK$4m	-HK$3m
Dec 31 2022	n/a	n/a	-HK$2m
Sep 30 2022	n/a	n/a	-HK$1m
Jun 30 2022	n/a	n/a	HK$2m
Mar 31 2022	HK$6m	HK$5m	HK$4m
Dec 31 2021	n/a	n/a	HK$908k
Sep 30 2021	n/a	n/a	HK$872k
Jun 30 2021	n/a	n/a	HK$2m
Mar 31 2021	HK$5m	HK$4m	HK$953k
Dec 31 2020	n/a	n/a	HK$931k
Sep 30 2020	n/a	n/a	-HK$750k
Jun 30 2020	n/a	n/a	-HK$2m
Mar 31 2020	HK$6m	HK$3m	-HK$3m
Dec 31 2019	n/a	n/a	-HK$3m
Sep 30 2019	n/a	n/a	-HK$3m
Jun 30 2019	n/a	n/a	-HK$5m
Mar 31 2019	HK$7m	HK$3m	-HK$5m
Dec 31 2018	n/a	n/a	-HK$2m
Sep 30 2018	n/a	n/a	-HK$1m
Jun 30 2018	n/a	n/a	HK$722k
Mar 31 2018	HK$7m	HK$3m	HK$3m

Compensación vs. Mercado: La compensación total de Kwok Leung($USD791.24K) está por encima de la media de empresas de tamaño similar en el mercado Hong Kong ($USD233.52K).

Compensación vs. Ingresos: La compensación de Kwok Leung ha aumentado mientras la empresa no es rentable.

CEO

Kwok Leung Kong (69 yo)

6.2yrs

Permanencia

HK$6,195,000

Compensación

Dr. Kwok Leung Kong serves as Chief Executive officer of Medicskin Holdings Ltd (“Company”) since March 01, 2018 and serves as its Founder and Chairman of the Board. Dr. Kong graduated from the Faculty of...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kwok Leung Kong	Founder	6.2yrs	HK$6.20m	69.28% HK$ 53.3m
Chui Pik Sin	CFO, Company Secretary & Executive Director	10.2yrs	HK$1.01m	sin datos
Chung Wai Kong	Legal & Compliance Officer and Executive Director	no data	HK$508.00k	sin datos
Kan Tsui	VP & Executive Director	no data	HK$622.00k	sin datos
Sze Suet Ling	Head of Business & Product Development and Medicskin Centre Manager	11.3yrs	sin datos	sin datos

10.2yrs

Permanencia media

44yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 8307 es experimentado (10.1 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kwok Leung Kong	Founder	9.9yrs	HK$6.20m	69.28% HK$ 53.3m
Chui Pik Sin	CFO, Company Secretary & Executive Director	7.3yrs	HK$1.01m	sin datos
Chung Wai Kong	Legal & Compliance Officer and Executive Director	9.8yrs	HK$508.00k	sin datos
Kan Tsui	VP & Executive Director	6.2yrs	HK$622.00k	sin datos
Siu Cheung Leung	Independent Non-Executive Director	9.4yrs	HK$180.00k	sin datos
Cheong Tat Chan	Independent Non-Executive Director	9.4yrs	HK$180.00k	sin datos
Sze On Lui	Independent Non-Executive Director	less than a year	sin datos	sin datos

9.4yrs

Permanencia media

51yo

Promedio de edad

Junta con experiencia: La junta directiva de 8307 se considera experimentada (9.3 años de antigüedad promedio).

Medicskin Holdings Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

We Think Some Shareholders May Hesitate To Increase Medicskin Holdings Limited's (HKG:8307) CEO Compensation

Medicskin Holdings Limited Announces Appointment of Lui Sze On as Independent Non-Executive Director and Member of the Audit Committee, Remuneration Committee and Nomination Committee of the Board with Effect from September 6, 2023

Medicskin Holdings Limited, Annual General Meeting, Sep 01, 2023

Medicskin Holdings Limited Announces Resignation of Fu Frank Tsun Yin as Independent Non-Executive Director and A Member of the Audit Committee, Remuneration Committee and Nomination Committee

Medicskin Holdings Limited Appoints Fu Frank Tsun Yin as an Independent Non-Executive Director and A Member of Each of the Audit Committee, Remuneration Committee and Nomination Committee of the Board with Effect from 14 February 2023

Medicskin Holdings Limited Announces Resignation of Lee Ka Lun as Independent Non-Executive Director and Member of the Audit Committee, Remuneration Committee and Nomination Committee

Recent updates

New minor risk - Share price stability

Now 20% overvalued after recent price rise

Now 23% undervalued after recent price drop

Second quarter 2024 earnings released: HK$0.004 loss per share (vs HK$0.006 loss in 2Q 2023)

New major risk - Market cap size

Medicskin Holdings Limited to Report Q2, 2024 Results on Nov 13, 2023

We Think Some Shareholders May Hesitate To Increase Medicskin Holdings Limited's (HKG:8307) CEO Compensation

Medicskin Holdings Limited Announces Appointment of Lui Sze On as Independent Non-Executive Director and Member of the Audit Committee, Remuneration Committee and Nomination Committee of the Board with Effect from September 6, 2023

New minor risk - Financial position

First quarter 2024 earnings released: HK$0.001 loss per share (vs HK$0.002 loss in 1Q 2023)

First quarter 2024 earnings released: HK$0.001 loss per share (vs HK$0.002 loss in 1Q 2023)

Medicskin Holdings Limited to Report Q1, 2024 Results on Aug 14, 2023

Medicskin Holdings Limited, Annual General Meeting, Sep 01, 2023

New minor risk - Share price stability

Full year 2023 earnings released: HK$0.007 loss per share (vs HK$0.01 profit in FY 2022)

Medicskin Holdings Limited Announces Resignation of Fu Frank Tsun Yin as Independent Non-Executive Director and A Member of the Audit Committee, Remuneration Committee and Nomination Committee

Medicskin Holdings Limited to Report Fiscal Year 2023 Results on Jun 21, 2023

Medicskin Holdings Limited Appoints Fu Frank Tsun Yin as an Independent Non-Executive Director and A Member of Each of the Audit Committee, Remuneration Committee and Nomination Committee of the Board with Effect from 14 February 2023

Third quarter 2023 earnings released: EPS: HK$0 (vs HK$0.004 in 3Q 2022)

Medicskin Holdings Limited to Report Q3, 2023 Results on Feb 13, 2023

Second quarter 2023 earnings released: HK$0.006 loss per share (vs HK$0.001 profit in 2Q 2022)

Medicskin Holdings Limited Announces Resignation of Lee Ka Lun as Independent Non-Executive Director and Member of the Audit Committee, Remuneration Committee and Nomination Committee

Less than half of directors are independent

Medicskin Holdings Limited Provides Unaudited Consolidated Earnings Guidance for Six Months Ended 30 September 2022

Medicskin Holdings Limited to Report First Half, 2023 Results on Nov 14, 2022

Here's Why Shareholders May Want To Be Cautious With Increasing Medicskin Holdings Limited's (HKG:8307) CEO Pay Packet

First quarter 2023 earnings released: HK$0.002 loss per share (vs HK$0.004 profit in 1Q 2022)

Medicskin Holdings Limited Provides Consolidated Earnings Guidance for the Three Months Ended June 30, 2022

Here's Why We Think Medicskin Holdings (HKG:8307) Is Well Worth Watching

Medicskin Holdings Limited, Annual General Meeting, Sep 23, 2022

Full year 2022 earnings released

Medicskin Holdings Limited, Annual General Meeting, Sep 23, 2022

Investor Optimism Abounds Medicskin Holdings Limited (HKG:8307) But Growth Is Lacking

Medicskin Holdings Limited to Report Fiscal Year 2022 Results on Jun 20, 2022

Less than half of directors are independent

Now 20% undervalued

A Look At The Fair Value Of Medicskin Holdings Limited (HKG:8307)

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS HK$0.001 (vs HK$0.002 in 2Q 2021)

Shareholders Will Probably Hold Off On Increasing Medicskin Holdings Limited's (HKG:8307) CEO Compensation For The Time Being

First quarter 2022 earnings released: EPS HK$0.004 (vs HK$0.002 in 1Q 2021)

Inaugural dividend of HK$0.025 per share

Full year 2021 earnings released: EPS HK$0.002 (vs HK$0.007 loss in FY 2020)

Medicskin Holdings Limited Announces Special Dividend for the Year Ended 31 March 2021, Payable on or around 26 July 2021

New 90-day high: HK$0.29

Can Mixed Fundamentals Have A Negative Impact on Medicskin Holdings Limited (HKG:8307) Current Share Price Momentum?

Third quarter 2021 earnings released: EPS HK$0.004 (vs HK$0.001 loss in 3Q 2020)

New 90-day high: HK$0.28

Medicskin Holdings Limited to Report Nine Months, 2021 Results on Feb 10, 2021

New 90-day high: HK$0.22

Our Take On Medicskin Holdings' (HKG:8307) CEO Salary

New 90-day high: HK$0.21

Second quarter 2021 earnings released: EPS HK$0.002

Medicskin Holdings Limited to Report First Half, 2021 Results on Nov 13, 2020

First quarter earnings released

Medicskin Holdings Limited to Report Q1, 2021 Results on Aug 14, 2020

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad